Yasmin
Yasmin is a pharmaceutical drug with 10 clinical trials. Historical success rate of 66.7%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
4 of 6 finished
33.3%
2 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Continuous Versus Cyclical OCP Use in PCOS
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis
A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.
Clinical Trials (10)
Continuous Versus Cyclical OCP Use in PCOS
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis
A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.
Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri
Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome
Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome
Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome
A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10